{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,1,5]],"date-time":"2026-01-05T11:19:50Z","timestamp":1767611990805,"version":"3.37.3"},"reference-count":27,"publisher":"Springer Science and Business Media LLC","issue":"10","license":[{"start":{"date-parts":[[2023,8,3]],"date-time":"2023-08-03T00:00:00Z","timestamp":1691020800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.springernature.com\/gp\/researchers\/text-and-data-mining"},{"start":{"date-parts":[[2023,8,3]],"date-time":"2023-08-03T00:00:00Z","timestamp":1691020800000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/www.springernature.com\/gp\/researchers\/text-and-data-mining"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Ann Surg Oncol"],"published-print":{"date-parts":[[2023,10]]},"DOI":"10.1245\/s10434-023-13894-6","type":"journal-article","created":{"date-parts":[[2023,8,3]],"date-time":"2023-08-03T15:02:10Z","timestamp":1691074930000},"page":"6159-6166","update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":2,"title":["A Look at the Other Side: High-Risk Lesions and Occult Contralateral Malignancy in Symmetry Procedures for Patients Undergoing Oncoplastic Breast-Conserving Surgery"],"prefix":"10.1245","volume":"30","author":[{"ORCID":"https:\/\/orcid.org\/0000-0001-9376-4939","authenticated-orcid":false,"given":"Katherine M.","family":"Jackson","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Janelle-Cheri","family":"Millen","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Javier I. J.","family":"Orozco","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Stacey L.","family":"Stern","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Crystal E.","family":"Fancher","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Janie G.","family":"Grumley","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"297","published-online":{"date-parts":[[2023,8,3]]},"reference":[{"key":"13894_CR1","doi-asserted-by":"publisher","first-page":"286","DOI":"10.1136\/jcp.2003.012427","volume":"57","author":"IS Cook","year":"2004","unstructured":"Cook IS, Fuller CE. Does histopathological examination of breast reduction specimens affect patient management and clinical follow up? J Clin Pathol. 2004;57:286\u20139.","journal-title":"J Clin Pathol"},{"key":"13894_CR2","doi-asserted-by":"publisher","DOI":"10.1155\/2012\/145630","volume":"2012","author":"BC Freedman","year":"2012","unstructured":"Freedman BC, et al. Incidence of occult carcinoma and high-risk lesions in mammaplasty specimens. Int J Breast Cancer. 2012;2012:145630.","journal-title":"Int J Breast Cancer"},{"key":"13894_CR3","doi-asserted-by":"publisher","first-page":"226","DOI":"10.1177\/229255031302100414","volume":"21","author":"JT Goodwin","year":"2013","unstructured":"Goodwin JT, et al. The management of incidental findings of reduction mammoplasty specimens. Can J Plast Surg. 2013;21:226\u20138.","journal-title":"Can J Plast Surg"},{"key":"13894_CR4","doi-asserted-by":"publisher","first-page":"741","DOI":"10.1007\/s10549-019-05335-4","volume":"177","author":"R Tang","year":"2019","unstructured":"Tang R, et al. Incidental breast carcinoma: incidence, management, and outcomes in 4804 bilateral reduction mammoplasties. Breast Cancer Res Treat. 2019;177:741\u20138.","journal-title":"Breast Cancer Res Treat"},{"key":"13894_CR5","doi-asserted-by":"publisher","first-page":"17","DOI":"10.3389\/fsurg.2018.00017","volume":"5","author":"M Waldner","year":"2018","unstructured":"Waldner M, et al. Occurrence of occult malignancies in reduction mammoplasties. Front Surg. 2018;5:17.","journal-title":"Front Surg"},{"key":"13894_CR6","doi-asserted-by":"publisher","first-page":"679","DOI":"10.1007\/s10549-018-4953-1","volume":"172","author":"H Yamauchi","year":"2018","unstructured":"Yamauchi H, et al. High rate of occult cancer found in prophylactic mastectomy specimens despite thorough presurgical assessment with MRI and ultrasound: findings from the Hereditary Breast and Ovarian Cancer Registration 2016 in Japan. Breast Cancer Res Treat. 2018;172:679\u201387.","journal-title":"Breast Cancer Res Treat"},{"key":"13894_CR7","doi-asserted-by":"publisher","first-page":"117e","DOI":"10.1097\/PRS.0000000000006965","volume":"146","author":"SE Fitzpatrick","year":"2020","unstructured":"Fitzpatrick SE, Lam TC. Occult breast carcinoma is more common in women undergoing breast reduction after contralateral cancer: a systematic review and meta-analysis. Plast Reconstr Surg. 2020;146:117e-e126.","journal-title":"Plast Reconstr Surg"},{"key":"13894_CR8","doi-asserted-by":"publisher","first-page":"341","DOI":"10.1016\/j.cps.2015.12.001","volume":"43","author":"GW Carlson","year":"2016","unstructured":"Carlson GW. The management of breast cancer detected by reduction mammaplasty. Clin Plast Surg. 2016;43:341\u20137.","journal-title":"Clin Plast Surg"},{"key":"13894_CR9","doi-asserted-by":"publisher","DOI":"10.1097\/GOX.0000000000004509","volume":"10","author":"TA Martin","year":"2022","unstructured":"Martin TA, et al. Outcomes of margin reexcision after oncoplastic breast reduction. Plast Reconstr Surg Glob Open. 2022;10:e4509.","journal-title":"Plast Reconstr Surg Glob Open"},{"key":"13894_CR10","doi-asserted-by":"publisher","first-page":"5677","DOI":"10.1245\/s10434-021-10450-y","volume":"28","author":"V Huynh","year":"2021","unstructured":"Huynh V, et al. Early trajectories of patient reported outcomes in breast cancer patients undergoing lumpectomy versus mastectomy. Ann Surg Oncol. 2021;28:5677\u201385.","journal-title":"Ann Surg Oncol"},{"key":"13894_CR11","doi-asserted-by":"publisher","first-page":"816","DOI":"10.1016\/j.amjsurg.2019.04.006","volume":"219","author":"M Jay","year":"2020","unstructured":"Jay M, Creelman B, Baliski C. Patient-reported outcomes associated with surgical intervention for breast cancer. Am J Surg. 2020;219:816\u201322.","journal-title":"Am J Surg"},{"key":"13894_CR12","doi-asserted-by":"publisher","first-page":"628","DOI":"10.1001\/jamasurg.2021.1438","volume":"156","author":"J de Boniface","year":"2021","unstructured":"de Boniface J, Szulkin R, Johansson ALV. Survival after breast conservation vs mastectomy adjusted for comorbidity and socioeconomic status: a Swedish national 6-year follow-up of 48 986 women. JAMA Surg. 2021;156:628\u201337.","journal-title":"JAMA Surg"},{"key":"13894_CR13","doi-asserted-by":"publisher","first-page":"201","DOI":"10.1503\/cjs.038109","volume":"54","author":"AG Horo","year":"2011","unstructured":"Horo AG, et al. Mammoplasty for symmetry in breast reconstruction and histologic assessment. Can J Surg. 2011;54:201\u20135.","journal-title":"Can J Surg"},{"key":"13894_CR14","doi-asserted-by":"publisher","first-page":"6660","DOI":"10.1245\/s10434-022-11916-3","volume":"29","author":"SM Wong","year":"2022","unstructured":"Wong SM, et al. Incidence of occult breast cancer in carriers of BRCA1\/2 or other high-penetrance pathogenic variants undergoing prophylactic mastectomy: when is sentinel lymph node biopsy indicated? Ann Surg Oncol. 2022;29:6660\u20138.","journal-title":"Ann Surg Oncol"},{"key":"13894_CR15","doi-asserted-by":"publisher","first-page":"21","DOI":"10.1007\/s00428-021-03173-8","volume":"480","author":"SE Pinder","year":"2022","unstructured":"Pinder SE, Thompson AM, Wesserling J. Low-risk DCIS: what is it? Observe or excise? Virchows Arch. 2022;480:21\u201332.","journal-title":"Virchows Arch"},{"key":"13894_CR16","doi-asserted-by":"publisher","first-page":"3206","DOI":"10.1245\/s10434-023-13370-1","volume":"30","author":"AL Nash","year":"2023","unstructured":"Nash AL, Hwang ES. The landmark series: ductal carcinoma in situ: the evolution of treatment. Ann Surg Oncol. 2023;30:3206\u201314.","journal-title":"Ann Surg Oncol"},{"key":"13894_CR17","doi-asserted-by":"publisher","first-page":"3184","DOI":"10.1200\/JCO.22.02553","volume":"41","author":"JC Boughey","year":"2023","unstructured":"Boughey JC, et al. Local recurrence after breast-conserving therapy in patients with multiple ipsilateral breast cancer: results from ACOSOG Z11102 (Alliance). J Clin Oncol. 2023;41:3184\u201393.","journal-title":"J Clin Oncol"},{"key":"13894_CR18","doi-asserted-by":"publisher","first-page":"427","DOI":"10.1245\/s10434-021-10800-w","volume":"29","author":"F De Lorenzi","year":"2022","unstructured":"De Lorenzi F, et al. Oncoplastic breast-conserving surgery for synchronous multicentric and multifocal tumors: is it oncologically safe? A retrospective matched-cohort analysis. Ann Surg Oncol. 2022;29:427\u201336.","journal-title":"Ann Surg Oncol"},{"key":"13894_CR19","doi-asserted-by":"publisher","first-page":"1231","DOI":"10.1007\/s003300050281","volume":"7","author":"C Boetes","year":"1997","unstructured":"Boetes C, et al. False-negative MR imaging of malignant breast tumors. Eur Radiol. 1997;7:1231\u20134.","journal-title":"Eur Radiol"},{"key":"13894_CR20","doi-asserted-by":"publisher","first-page":"150","DOI":"10.1093\/jncimonographs\/lgq030","volume":"2010","author":"CD Lehman","year":"2010","unstructured":"Lehman CD. Magnetic resonance imaging in the evaluation of ductal carcinoma in situ. J Natl Cancer Inst Monogr. 2010;2010:150\u20131.","journal-title":"J Natl Cancer Inst Monogr"},{"key":"13894_CR21","doi-asserted-by":"publisher","first-page":"485","DOI":"10.1016\/S0140-6736(07)61232-X","volume":"370","author":"CK Kuhl","year":"2007","unstructured":"Kuhl CK, et al. MRI for diagnosis of pure ductal carcinoma in situ: a prospective observational study. Lancet. 2007;370:485\u201392.","journal-title":"Lancet"},{"key":"13894_CR22","doi-asserted-by":"publisher","first-page":"103","DOI":"10.1111\/tbj.13162","volume":"25","author":"A Allen","year":"2019","unstructured":"Allen A, et al. Evaluating the frequency of upgrade to malignancy following surgical excision of high-risk breast lesions and ductal carcinoma in situ identified by core needle biopsy. Breast J. 2019;25:103\u20136.","journal-title":"Breast J"},{"key":"13894_CR23","doi-asserted-by":"publisher","first-page":"534","DOI":"10.1016\/j.amjsurg.2006.06.003","volume":"192","author":"JA Margenthaler","year":"2006","unstructured":"Margenthaler JA, et al. Correlation between core biopsy and excisional biopsy in breast high-risk lesions. Am J Surg. 2006;192:534\u20137.","journal-title":"Am J Surg"},{"key":"13894_CR24","doi-asserted-by":"publisher","first-page":"24","DOI":"10.1016\/j.amjsurg.2013.05.014","volume":"207","author":"TS Menes","year":"2014","unstructured":"Menes TS, et al. Upgrade of high-risk breast lesions detected on mammography in the Breast Cancer Surveillance Consortium. Am J Surg. 2014;207:24\u201331.","journal-title":"Am J Surg"},{"key":"13894_CR25","doi-asserted-by":"publisher","first-page":"1471","DOI":"10.1038\/modpathol.2016.127","volume":"29","author":"KL Mooney","year":"2016","unstructured":"Mooney KL, Bassett LW, Apple SK. Upgrade rates of high-risk breast lesions diagnosed on core needle biopsy: a single-institution experience and literature review. Mod Pathol. 2016;29:1471\u201384.","journal-title":"Mod Pathol"},{"key":"13894_CR26","doi-asserted-by":"publisher","first-page":"67","DOI":"10.3233\/BD-180379","volume":"38","author":"M Kupsik","year":"2019","unstructured":"Kupsik M, Perez C, Bargaje A. Upstaging papillary lesions to carcinoma on surgical excision is not impacted by patient race. Breast Dis. 2019;38:67\u201372.","journal-title":"Breast Dis"},{"key":"13894_CR27","doi-asserted-by":"publisher","first-page":"2501","DOI":"10.1245\/s10434-016-5182-7","volume":"23","author":"T Tatarian","year":"2016","unstructured":"Tatarian T, et al. Intraductal papilloma with benign pathology on breast core biopsy: to excise or not? Ann Surg Oncol. 2016;23:2501\u20137.","journal-title":"Ann Surg Oncol"}],"container-title":["Annals of Surgical Oncology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1245\/s10434-023-13894-6.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1245\/s10434-023-13894-6\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1245\/s10434-023-13894-6.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2023,9,11]],"date-time":"2023-09-11T14:05:35Z","timestamp":1694441135000},"score":1,"resource":{"primary":{"URL":"https:\/\/link.springer.com\/10.1245\/s10434-023-13894-6"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2023,8,3]]},"references-count":27,"journal-issue":{"issue":"10","published-print":{"date-parts":[[2023,10]]}},"alternative-id":["13894"],"URL":"https:\/\/doi.org\/10.1245\/s10434-023-13894-6","relation":{},"ISSN":["1068-9265","1534-4681"],"issn-type":[{"type":"print","value":"1068-9265"},{"type":"electronic","value":"1534-4681"}],"subject":[],"published":{"date-parts":[[2023,8,3]]},"assertion":[{"value":"28 April 2023","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"14 June 2023","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"3 August 2023","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"There are no conflict of interest.","order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Disclosure"}}]}}